论文部分内容阅读
目的:对经静脉或动脉给予非离子型对比剂后,有血-脑屏障或血-脑脊液屏障破裂表现的患者,分析其临床表现和CT征象。方法:①回顾性分析8例经静脉或动脉给予非离子型对比剂(200~450ml)后,有血-脑屏障或血-脑脊液屏障破坏临床表现和CT征象的患者。②前瞻性分析30例患败血症并
OBJECTIVE: To analyze the clinical manifestations and CT signs in patients with blood-brain barrier or blood-cerebrospinal fluid barrier rupture after intravenous or arterial administration of non-ionic contrast agent. Methods: ①A retrospective analysis of 8 patients with blood-brain barrier or blood-cerebrospinal fluid barrier disruption clinical manifestations and CT signs after intravenous or arterial administration of non-ionic contrast agent (200-450ml). ② Prospective analysis of 30 cases of sepsis and